Matthias Karrasch1, Konstantin Herfurth2, Monika Kläver3, Jenny Miethke4, Anne Mayer-Scholl5, Enno Luge5, Eberhard Straube6, Martin Busch2. 1. Institute of Medical Microbiology, University Hospital of Friedrich-Schiller-University Jena, Erlanger Allee 101, 07743, Jena, Germany. matthias.karrasch@med.uni-jena.de. 2. Department of Internal Medicine III (Nephrology), University Hospital of Friedrich-Schiller-University Jena, Jena, Germany. 3. Institute of Diagnostic and Interventional Radiology, University Hospital of Friedrich-Schiller-University Jena, Jena, Germany. 4. Department of Internal Medicine II (Hematology/Oncology), University Hospital of Friedrich-Schiller-University Jena, Jena, Germany. 5. German Consiliary Laboratory for Leptospirosis, Federal Institute for Risk Assessment, Berlin, Germany. 6. Institute of Medical Microbiology, University Hospital of Friedrich-Schiller-University Jena, Erlanger Allee 101, 07743, Jena, Germany.
Abstract
INTRODUCTION: Weil's disease is a severe, potentially fatal illness following Leptospira interrogans infection. The reported case of a patient suffering from acute renal failure, jaundice, thrombocytopenia, rhabdomyolysis and encephalitis syndrome highlights the clinical challenge in reference to Weil syndrome complicated by Epstein-Barr Virus (EBV) reactivation. MATERIALS AND METHODS: The diagnosis of leptospirosis was performed using four different diagnostic methods. Sera were analyzed with an in-house IgM and IgG enzyme-linked immunosorbent assay (ELISA) and indirect haemagglutination assay (IHA). Microscopic agglutination test (MAT) was done using 17 reference strains comprising 14 serogroups and 17 serovars. Polyvalent EBV-IgG analysis, EBV-IgG/IgM/IgA western blot analysis as well as quantitative EBV polymerase chain reaction (PCR) were performed. RESULTS: Leptospira IHA showed an initial titer of 1:640 (cut-off 1:320), leptospiral IgG was negative, but IgM was positive. MAT was negative at that time for all 17 strains analyzed. One week later, leptospirosis IHA titer increased to 1:20,480. Leptospiral IgG was now positive, -IgM remained positive and urine was tested negative for leptospiral DNA. The MAT showed positive results for L. interrogans serovar Bataviae, serovar Copenhageni, serovar Pyrogenes and L. borgpetersenii serovar Serjoe. During follow-up examinations, both the leptospiral IgM and IgG remained positive and MAT showed positive results for L. interrogans of different serovars. EBV IgA immunoblot taken at admission was positive for VCA-p18, quantitative EBV-PCR showed an EBV viral load of 2.8E3 copies/ml indicating acute EBV-reactivation. CONCLUSION: Leptospirosis represents a neglected and re-emerging disease which is difficult to diagnose since Leptospira-PCR from whole blood or urine is frequently negative in the case of early empiric antibiotic treatment. EBV-reactivation might represent a severe complication in Weil's disease which potentially aggravates clinical manifestations of leptospirosis including hepatitis, nephritis, and rhabdomyolysis. Thus, there might be a need for peripheral blood EBV-PCR and EBV blotting in patients suffering from complicated Weil syndrome, also in terms of the choice of antibiotic treatment.
INTRODUCTION: Weil's disease is a severe, potentially fatal illness following Leptospira interrogans infection. The reported case of a patient suffering from acute renal failure, jaundice, thrombocytopenia, rhabdomyolysis and encephalitis syndrome highlights the clinical challenge in reference to Weil syndrome complicated by Epstein-Barr Virus (EBV) reactivation. MATERIALS AND METHODS: The diagnosis of leptospirosis was performed using four different diagnostic methods. Sera were analyzed with an in-house IgM and IgG enzyme-linked immunosorbent assay (ELISA) and indirect haemagglutination assay (IHA). Microscopic agglutination test (MAT) was done using 17 reference strains comprising 14 serogroups and 17 serovars. Polyvalent EBV-IgG analysis, EBV-IgG/IgM/IgA western blot analysis as well as quantitative EBV polymerase chain reaction (PCR) were performed. RESULTS: Leptospira IHA showed an initial titer of 1:640 (cut-off 1:320), leptospiral IgG was negative, but IgM was positive. MAT was negative at that time for all 17 strains analyzed. One week later, leptospirosis IHA titer increased to 1:20,480. Leptospiral IgG was now positive, -IgM remained positive and urine was tested negative for leptospiral DNA. The MAT showed positive results for L. interrogans serovar Bataviae, serovar Copenhageni, serovar Pyrogenes and L. borgpetersenii serovar Serjoe. During follow-up examinations, both the leptospiral IgM and IgG remained positive and MAT showed positive results for L. interrogans of different serovars. EBV IgA immunoblot taken at admission was positive for VCA-p18, quantitative EBV-PCR showed an EBV viral load of 2.8E3 copies/ml indicating acute EBV-reactivation. CONCLUSION: Leptospirosis represents a neglected and re-emerging disease which is difficult to diagnose since Leptospira-PCR from whole blood or urine is frequently negative in the case of early empiric antibiotic treatment. EBV-reactivation might represent a severe complication in Weil's disease which potentially aggravates clinical manifestations of leptospirosis including hepatitis, nephritis, and rhabdomyolysis. Thus, there might be a need for peripheral blood EBV-PCR and EBV blotting in patients suffering from complicated Weil syndrome, also in terms of the choice of antibiotic treatment.
Authors: S F Leung; K C A Chan; B B Ma; E P Hui; F Mo; K C K Chow; L Leung; K W Chu; B Zee; Y M D Lo; A T C Chan Journal: Ann Oncol Date: 2014-03-17 Impact factor: 32.976
Authors: D A Ashford; R M Kaiser; R A Spiegel; B A Perkins; R S Weyant; S L Bragg; B Plikaytis; C Jarquin; J O De Lose Reyes; J J Amador Journal: Am J Trop Med Hyg Date: 2000 Nov-Dec Impact factor: 2.345
Authors: Bastian A Vogl; Ursula Fagin; Linda Nerbas; Peter Schlenke; Peter Lamprecht; Wolfram J Jabs Journal: J Med Virol Date: 2012-01 Impact factor: 2.327
Authors: Hans-Joachim Wagner; Yee Chung Cheng; M Helen Huls; Adrian P Gee; Ingrid Kuehnle; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop Journal: Blood Date: 2004-01-29 Impact factor: 22.113
Authors: Julia R Hirsiger; Philipp S Fuchs; Peter Häusermann; Bojana Müller-Durovic; Thomas Daikeler; Mike Recher; Hans H Hirsch; Luigi Terracciano; Christoph T Berger Journal: Open Forum Infect Dis Date: 2019-07-03 Impact factor: 3.835
Authors: Hisham Ahmed Imad; Aishath Azna Ali; Mariyam Nahuza; Rajan Gurung; Abdulla Ubaid; Aishath Maeesha; Sariu Ali Didi; Rajib Kumar Dey; Abdullah Isneen Hilmy; Aishath Hareera; Ibrahim Afzal; Wasin Matsee; Wang Nguitragool; Emi E Nakayama; Tatsuo Shioda Journal: Trop Med Infect Dis Date: 2021-12-08